A detailed history of Amalgamated Bank transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 351 shares of IGMS stock, worth $6,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
351
Previous 351 -0.0%
Holding current value
$6,258
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$8.68 - $17.36 $5,537 - $11,075
-638 Reduced 64.51%
351 $3,000
Q4 2023

Feb 06, 2024

SELL
$3.94 - $8.79 $409 - $914
-104 Reduced 9.52%
989 $8,000
Q2 2023

Aug 11, 2023

SELL
$8.86 - $14.0 $2,445 - $3,864
-276 Reduced 20.16%
1,093 $10,000
Q1 2023

May 02, 2023

SELL
$13.74 - $25.76 $2,954 - $5,538
-215 Reduced 13.57%
1,369 $19,000
Q3 2022

Nov 09, 2022

BUY
$15.42 - $27.01 $1,063 - $1,863
69 Added 4.55%
1,584 $36,000
Q2 2022

Aug 15, 2022

BUY
$13.27 - $25.5 $2,388 - $4,590
180 Added 13.48%
1,515 $27,000
Q1 2022

Jun 30, 2022

BUY
$13.42 - $29.73 $17,915 - $39,689
1,335 New
1,335 $36,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $517M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.